European Healthtech startup funding raised during October 2023.
In October 2023, 44 European Healthtech companies raised a combined €321M across 44 funding rounds, down 55.8% versus October 2022. Belgium led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Agomab Therapeutics | Series C | Oct 2023 | €95M |
| MinervaX | Other | Oct 2023 | €54M |
| Automata Technologies | Other | Oct 2023 | €38M |
| Lottie | Series A |
| Acquisition |
| Oct 2023 |
| €1.1B |
| Oct 2023 |
| €20M |
| Laverock Therapeutics | Seed | Oct 2023 | €16M |
| Astraveus | Grant | Oct 2023 | €10M |
| Mogrify | Series A | Oct 2023 | €9.6M |
| Kranus Health | Other | Oct 2023 | €8.1M |
| Poppins | Other | Oct 2023 | €8.0M |
| Predisurge | Series A | Oct 2023 | €6.5M |
| Synerkine Pharma | Series A | Oct 2023 | €5.3M |
| Hippo Dx | Other | Oct 2023 | €4.4M |
| Follow | Series A | Oct 2023 | €3.8M |
| Inovedis | Series A | Oct 2023 | €3.8M |
| RAYDIAX | Other | Oct 2023 | €3.5M |
